Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Tartaglia Lab, |
RCV000984019 | SCV000925232 | pathogenic | Rahman syndrome | 2019-05-01 | criteria provided, single submitter | research | |
Ambry Genetics | RCV001266839 | SCV001445019 | likely pathogenic | Inborn genetic diseases | 2018-06-06 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001268306 | SCV001447136 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000984019 | SCV004801444 | pathogenic | Rahman syndrome | 2020-05-01 | criteria provided, single submitter | clinical testing | The HIST1H1E c.414dupC p.(Lys139GlnfsTer57) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. This frameshift event occurs in a mutational hotspot in the carboxy terminal domain of the gene (Burkardt et al. 2019) and it is predicted to result in an expressed, truncated protein that contains the recurrent 38 amino acid carboxy-terminal motif shared among affected individuals (Flex et al. 2019). This variant has been identified in individuals with a phenotype consistent with Rahman syndrome, in at least one of whom, the variant occurred in a de novo state (Flex et al. 2019). This variant is not observed in version 2.1.1 of the Genome Aggregation Database. The variant was identified in a de novo state in the proband. Based on the available evidence the c.414dupC p.(Lys139GlnfsTer57) variant is classified as pathogenic for Rahman syndrome. |
Gene |
RCV000984019 | SCV001468683 | not provided | Rahman syndrome | no assertion provided | literature only |